Page last updated: 2024-08-22

samarium and melphalan

samarium has been researched along with melphalan in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berger, JD; Claringbold, PG; Glancy, RJ; Manning, LS; O'Donoghue, HL; Turner, JH1
Bares, R; Dohmen, BM; Einsele, H; Kanz, L; Knop, S1
Anderson, PM; Ansell, SM; Dispenzieri, A; Elliott, MA; Erlichman, C; Fonseca, R; Gastineau, DA; Gertz, MA; Greipp, PR; Inwards, DJ; Lacy, MQ; Litzow, MR; Lust, JA; Micallef, IN; Porrata, L; Rajkumar, SV; Sloan, JA; Tefferi, A; Wiseman, GA; Witzig, TE1
Anderson, PM; Arndt, CA; Erlandson, L; Rodriguez, V; Wiseman, GA1
Allred, J; Ansell, SM; Buadi, F; Dingli, D; Dispenzieri, A; Elliott, MA; Gastineau, DA; Gertz, MA; Geyer, SM; Hayman, SR; Hogan, WJ; Inwards, DJ; Johnston, PB; Kumar, SK; Lacy, MQ; Laumann, KM; Litzow, MR; Micallef, IN; Porrata, L; Wiseman, GA1

Trials

2 trial(s) available for samarium and melphalan

ArticleYear
A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma.
    Leukemia, 2005, Volume: 19, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Humans; Male; Maximum Tolerated Dose; Melphalan; Middle Aged; Multiple Myeloma; Organometallic Compounds; Organophosphorus Compounds; Radioisotopes; Samarium; Stem Cell Transplantation; Tissue Distribution; Transplantation Conditioning

2005
A Phase II study of (153)Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma.
    American journal of hematology, 2010, Volume: 85, Issue:6

    Topics: Adult; Aged; Bone Marrow; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Male; Melphalan; Middle Aged; Multiple Myeloma; Myeloablative Agonists; Organometallic Compounds; Organophosphorus Compounds; Pain; Peripheral Blood Stem Cell Transplantation; Radioisotopes; Radiopharmaceuticals; Radiotherapy Dosage; Salvage Therapy; Samarium; Tissue Distribution; Transplantation Conditioning

2010

Other Studies

3 other study(ies) available for samarium and melphalan

ArticleYear
Radiopharmaceutical therapy of 5T33 murine myeloma by sequential treatment with samarium-153 ethylenediaminetetramethylene phosphonate, melphalan, and bone marrow transplantation.
    Journal of the National Cancer Institute, 1993, Sep-15, Volume: 85, Issue:18

    Topics: Animals; Bone Marrow Transplantation; Combined Modality Therapy; Female; In Vitro Techniques; Male; Melphalan; Mice; Mice, Inbred C57BL; Multiple Myeloma; Organometallic Compounds; Organophosphorus Compounds; Samarium; Survival Analysis; Tumor Cells, Cultured

1993
153 Samarium-EDTMP in myeloablative dosage followed by a second autotransplantation in patients with relapsed multiple myeloma.
    Haematologica, 2004, Volume: 89, Issue:9

    Topics: Fatal Outcome; Graft Survival; Humans; Male; Melphalan; Multiple Myeloma; Organometallic Compounds; Organophosphorus Compounds; Osteolysis; Peripheral Blood Stem Cell Transplantation; Radioisotopes; Radiopharmaceuticals; Salvage Therapy; Samarium; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome

2004
Low toxicity and efficacy of (153)samarium-EDTMP and melphalan as a conditioning regimen for secondary acute myelogenous leukemia.
    Pediatric transplantation, 2005, Volume: 9, Issue:1

    Topics: Adolescent; Female; Humans; Leukemia, Myeloid, Acute; Melphalan; Organometallic Compounds; Organophosphorus Compounds; Radioisotopes; Samarium; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Autologous

2005
chemdatabank.com